Literature DB >> 25502490

The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study.

Joao Paulo Maia-de-Oliveira1, Joao Abrao, Paulo R Evora, Antonio W Zuardi, Jose A S Crippa, Paulo Belmonte-de-Abreu, Glen B Baker, Serdar M Dursun, Jaime E C Hallak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25502490     DOI： 10.1097/JCP.0000000000000258

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  7 in total

1.  Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders.

Authors:  Tyler Grove; Stephan Taylor; Gregory Dalack; Vicki Ellingrod
Journal:  Schizophr Res       Date:  2015-02-23       Impact factor: 4.939

2.  Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: The SHR strain.

Authors:  Mariana C Diana; Fernanda F Peres; Veronica Justi; Rodrigo A Bressan; Acioly L T Lacerda; José Alexandre Crippa; Jaime E C Hallak; Vanesssa Costhek Abilio
Journal:  CNS Neurosci Ther       Date:  2018-04-14       Impact factor: 5.243

3.  MK-801-induced impairments on the trial-unique, delayed nonmatching-to-location task in rats: effects of acute sodium nitroprusside.

Authors:  Jessica L Hurtubise; Wendie N Marks; Don A Davies; Jillian K Catton; Glen B Baker; John G Howland
Journal:  Psychopharmacology (Berl)       Date:  2016-10-10       Impact factor: 4.530

4.  Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial.

Authors:  Hannah E Brown; Oliver Freudenreich; Xiaoduo Fan; Stephen O Heard; Donald Goff; George Petrides; Amy L Harrington; John M Kane; Heidi Judge; Bettina Hoeppner; Maurizio Fava; Roy H Perlis
Journal:  JAMA Psychiatry       Date:  2019-07-01       Impact factor: 21.596

Review 5.  Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator.

Authors:  Silvia Hoirisch-Clapauch; Antonio E Nardi
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

Review 6.  The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders.

Authors:  Manish Kumar Tripathi; Maryam Kartawy; Haitham Amal
Journal:  Redox Biol       Date:  2020-05-15       Impact factor: 11.799

Review 7.  The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows.

Authors:  Elli Zoupa; Nikolaos Pitsikas
Journal:  Molecules       Date:  2021-05-26       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.